David M. Polen
Polen Capital Management
Polen Capital Management Portfolio 13F
Polen Capital Management Holdings Activity
- Portfolio value:
- $4.58B≈ (-$44M≈)
- Previous value:
- $4.62B≈
- # of changes:
- 25
- New positions:
- 3
- Reported for:
- 30 Jun 2014 (Q2)
- Latest filing date:
- 13 Aug 2014
Polen Capital Management has disclosed a total of 25 changes to the portfolio in the (2014 Q2) SEC report(s): increased the number of shares of 1, bought 3 totally new, decreased the number of shares of 20 and completely sold out 1 position(s).
What did Polen Capital Management invest in during 2014 Q2?
In the 2014 Q2 report(s) the following changes have been made to the top investments: (AGN-OLD) ALLERGAN INC/UNITED STATES (reduced shares -4.81%), (V) Visa Inc, CL-A (reduced shares -4.89%), (QCOM) Qualcomm Incorporated (reduced shares -5.00%), (ABT) Abbott Laboratories (reduced shares -4.97%) and (ORCL) Oracle Corp (reduced shares -4.94%).
25 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Alphabet Inc, CL-C
|
new
|
$28.68
|
+1,150.75%($358.69)
|
4.45%
|
2014 Q2
|
≈ 0.25 years
|
||||
|
|
Nestle SA ADR
|
new
|
$77.67
|
+29.86%($100.86)
|
4.42%
|
2014 Q2
|
≈ 0.25 years
|
||||
|
|
Booking Holdings Inc
|
new
|
$48.12
|
+331.95%($207.86)
|
2.09%
|
2014 Q2
|
≈ 0.25 years
|
||||
|
|
iShares Russell 1000 Growth ETF
|
+132.90%
|
$22.74
|
+447.43%($124.47)
|
0.03%
|
2013 Q4
|
≈ 0.75 years
|
||||
|
|
Automatic Data Processing Inc
|
-4.27%
|
$79.28
|
+240.30%($269.79)
|
4.06%
|
2013 Q3
|
≈ 1.00 year
|
||||
|
|
WW Grainger Inc
|
-4.64%
|
$254.27
|
+409.71%($1,296.05)
|
3.47%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Fastenal Company
|
-4.71%
|
$12.37
|
+305.62%($50.18)
|
3.16%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Mastercard Inc
|
-4.78%
|
$73.47
|
+679.06%($572.38)
|
1.99%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
ALLERGAN INC/UNITED STATES
|
-4.81%
|
$169.22
|
|
9.32%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Regeneron Pharmaceuticals Inc
|
-4.82%
|
$282.47
|
+172.95%($771.00)
|
1.29%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.